ADAM8 and familial pancreatic carcinoma: Targeting ADAM8 with the peptide mimetic has been shown to enhance survival in pancreatic cancer (KPC) mouse models by reducing tumour volume, limiting metastasis, and decreasing tumour cell invasion while preserving acinar structures [124].